This is a StreetInsider.com Premium Only Page

Beam Therapeutics Inc. (BEAM) – Mergers and Acquisitions

Oct 31, 2023 06:00 AM Beam Therapeutics (BEAM) to Sell Opt-In Rights to Verve Therapeutics’ Base Editing Programs for Cardiovascular Disease to Eli Lilly for Up to $600M

Feb 23, 2021 08:35 AM Beam Therapeutics Inc. (BEAM) Announces Acquisition of Guide Therapeutics for $120M Upfront, Plus Milestone Payments

Jan 13, 2014 07:04 AM

Jan 22, 2013 06:47 AM

Apr 23, 2012 07:13 AM

Dec 16, 2011 07:03 AM

Oct 3, 2011 04:13 PM